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The  levamisole-sensitive  nicotinic  acetylcholine  receptor  present  at  nematode  neuromuscular  junc-
tions  is  composed  of multiple  different  subunits,  with  the  exact  composition  varying  between  species.
We  tested  the  ability  of two  well-conserved  nicotinic  receptor  subunits,  UNC-38  and  UNC-29,  from
Haemonchus  contortus  and  Ascaris  suum  to rescue  the  levamisole-resistance  and  locomotion  defects  of
Caenorhabditis  elegans  strains  with  null  deletion  mutations  in  the  unc-38  and  unc-29  genes.  The  parasite
cDNAs  were  cloned  downstream  of  the  relevant  C. elegans  promoters  and introduced  into  the  mutant




both  the locomotion  defects  and  levamisole  resistance  of the null  deletion  mutant  VC2937  (ok2896),  but
no C.  elegans  expressing  the A.  suum  UNC-38  could  be detected.  The  H. contortus  UNC-29.1  subunit  par-
tially  rescued  the levamisole  resistance  of  a C. elegans  null  mutation  in  unc-29  VC1944  (ok2450),  but  did
cause  increased  motility  in a thrashing  assay.  In contrast,  only  a single  line  of  worms  containing  the  A.
suum  UNC-29  subunit  showed  a  partial  rescue  of levamisole  resistance,  with  no effect  on  thrashing.
©  2015  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
The free-living nematode, Caenorhabditis elegans, makes an
ttractive expression system for genes from parasitic species as
t is cheap and easy to maintain in the laboratory, with no need
or experimentally infected animals to maintain the life-cycle, and
here are a plethora of powerful genetic tools available for its
anipulation. In recent years, a number of groups, including us,
ave reported the successful expression of proteins from para-
itic nematodes in C. elegans [1–8]. However, most, if not all, of
hese proteins are active as either monomers or homomeric multi-
ers. Many nicotinic acetylcholine receptors (nAChRs) and related
entameric ligand-gated ion channels are composed of multiple
ubunits which have to assemble to form an active protein. Nema-
ode nAChR, especially those found at the neuromuscular junction
nmj), are important anthelmintic drug targets and the sites of
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ax: +1 706 542 5771.
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166-6851/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
action of compounds such as levamisole, pyrantel, tribendimidine,
monepantel and derquantel [9,10].
The levamisole-sensitive nAChR present at the C. elegans neu-
romuscular junction are made up of five subunits, LEV-1, LEV-8,
UNC-29, UNC-38 and UNC-63 and, at least when expressed in vitro
in the Xenopus oocyte, the loss of any one of these makes the
receptor non-functional [11]. In addition, there is a levamisole-
insensitive nAChR that consists of a homo-pentamer of ACR-16
subunits [12]. The analogous receptors of parasitic nematodes
are likely to be similar; the levamisole-sensitive receptors of
Haemonchus contortus and Oesophagostonum dentatum can be
reconstituted in vitro from ACR-8, UNC-29, UNC-38 and UNC-63
subunits, though this is complicated by the presence of multi-
ple paralogs of the unc-29 gene in these organisms [13,14]. The
predicted protein product of the Hco-lev-1 gene (nomenclature as
described by Beech et al. [15]) is predicted to lack a signal peptide
and does not seem to be incorporated into the receptor in vitro [13].
Omission of the Hco-ACR-8 subunit resulted in the expression of a
pharmacologically distinct form of the receptor in vitro [13]. Func-
tional nAChR can be formed in vitro by the expression of only two
subunits from Ascaris suum, Asu-UNC-29 and Asu-UNC-38, and the
properties of the receptor vary with the subunit composition [16].
However, the genome sequence shows that orthologs of the unc-63
and acr-8 genes are present in this organism [17]. This complexity
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irrors that revealed by in vivo measurements on the muscle cells
f A. suum and O. dentatum where three or four distinct sub-types
f receptor can be resolved at the single-channel level [14,18,19].
Successful expression of individual nAChR subunits from para-
itic nematodes in C. elegans therefore requires that they are able
o co-assemble with endogenous host subunits to form a func-
ional receptor, unlike the glutamate-gated chloride channels we
tudied previously [1,2] many of which form functional homo-
eric receptors when expressed in vitro [20–23]. The aim of the
xperiments reported here was to test whether or not subunits
f nAChR from parasitic nematodes could assemble with endoge-
ous C. elegans subunits to form a functional levamisole-sensitive
icotinic receptor. We  chose to use the UNC-29 and UNC-38 sub-
nits of H. contortus and A. suum in these experiments because
hese subunits are conserved in all nematode genomes for which
e have sequence information and they are constituents of all the
ecombinant nematode levamisole-sensitive nAChR that have been
econstituted in the Xenopus oocyte system to date. In order to pre-
ent endogenous C. elegans UNC-29 and UNC-38 subunits, whether
unctional or not, interfering with the assembly of receptors incor-
orating the parasite subunits we used unc-29 and unc-38 deletion
utants of C. elegans as the hosts for these experiments. H. contor-
us is fairly closely related to C. elegans on nematode phylogenetic
rees, being placed in the same clade (clade V) as C. elegans by Blax-
er et al. [24]. and in clade 9B by van Megen et al., who place C.
legans in clade 9A [25]. A. suum is more distantly related to C. ele-
ans: Blaxter et al. place it in clade III and van Megen et al. in clade
B [24,25]. We  were interested in comparing the two  to see if phy-
ogenetic distance may  have any effect on the ability of the parasite
ubunits to functionally express in the C. elegans background.
. Methods and materials
.1. Materials
All the C. elegans strains used in this project were supplied by
he Caenorhabditis Genetics Center, St. Paul, MN,  USA. The plasmids
PD95.75 and pPD138.11 (Addgene plasmids # 1494 and # 1721)
ere a gift from Andrew Fire. Unless otherwise stated, all chemicals
ere from Sigma (St. Louis, MO,  USA).
.2. Transformation of C. elegans
We  constructed plasmids for transfection into C. elegans by
ub-cloning the full-length parasite cDNAs (Accession Num-
ers: Hco-unc-29.1 = EU006786.1; Asu-unc-29 = EU006073.1; Hco-
nc-38 = GU060984.1; Asu-unc-38 = EU053155.1) into a pGEM3-
erived plasmid, downstream of the putative C. elegans unc-29 or
nc-38 promoters. The promoter fragments used corresponded to
.4 kbp (unc-29) or 1.1 kbp (unc-38) of genomic sequence upstream
f the start codons, as these regions have been demonstrated previ-
usly to drive body-wall muscle expression of the subunits [26,27].
Biolistic transformation of C. elegans wild-type and mutant
trains was carried out essentially as described by Glendinning et al.
2], except that a myo-2:GFP construct (pPD138.11) was  used as
 co-transformant and candidate transformed lines picked on the
asis of pharyngeal GFP expression. This was to avoid the mus-
le cell expression of GFP under the myo-3 promoter causing any
roblems in the interpretation of the results. All plasmids were lin-
arized with Apa-1 (New England Biolabs, Ipswich, MA,  USA) at 25C
or 3 h prior to transformation..3. Identification of transgenic lines
To select the GFP-expressing transformants, the nematodes
ere viewed under a dissecting microscope (Olympus SZX7) withal Parasitology 204 (2015) 44–50 45
a Lumen Dynamics X-cite series 120Q light source and a GFP fil-
ter. Individuals expressing GFP in the pharynx were transferred
to individual 60 mm × 15 mm NGM plates with an OP50 lawn. The
presence of the test DNA was  verified for each line using single
worm PCR with primers specific for the parasite cDNA as described
[2].
2.4. C. elegans synchronization and motility scoring
Wild-type and mutant worms  were plated on NGM plates
seeded with OP50 Escherichia coli and allowed to mature to adult-
hood and lay eggs (4–6 days). Plates were washed with M9  to
remove adults and gently scraped with a Pasteur pipette to dis-
lodge eggs. M9 containing worms and eggs was centrifuged in a
15 ml  conical tube for 2 min  at 1500 RPM to pellet worms. The
pellet was washed with fresh M9  to remove residual OP50 and cen-
trifuged once more. Following the second wash, the supernatant
was removed and 5 ml  of bleach solution (0.5 ml 5 M NaOH + 1.5 ml
6% bleach + 3.5 ml  deionized water) was  added. Tubes were shaken,
vortexed, and rotated to dissolve worms for 5 min, or until only
eggs were visible. Tubes were then centrifuged at 1500 RPM for
2 min  to pellet eggs, and the supernatant was  immediately removed
and replaced by 3 ml  fresh M9.  The solution was poured over an
unseeded NGM plate (60 mm)  and placed on a bench-top rocker
(KSA 250 Basic) set to 150 RPM overnight. Once hatched, L1 worms
were collected and placed on seeded plates and allowed to grow to
early adulthood (∼56 h, pre-egg laying) at 19 ◦C for use in motility
assays. Assays were setup in 96 well plates with approximately 100
third-stage larvae (L3) or 50 adults per well. All experiments were
run in triplicate and their motility measured on the ‘Worminator’
as described [28]. Videos were recorded for approximately 30 s per
well.
2.5. Levamisole sensitivity assays
The drug sensitivity of the transgenic lines, as well as the wild
type and mutant strains, was tested by incubation in different con-
centrations of levamisole. Worms  were washed off a week old
60 mm  × 15 mm  NGM plate with 1 ml  of M9  buffer; this population
contained a mixture of developmental stages. This was then diluted
with M9  buffer to a concentration of approximately 50 worms  per
20 l. A stock solution of 1 mM levamisole was made by dissolv-
ing 0.024 g of levamisole in 100 ml  of distilled water. This was  then
divided into 10 ml  aliquots and immediately frozen until required.
From these 10 ml  1 mM stocks 1 ml  was  used in 6 × 1:10 serial
dilutions to generate the following drug concentrations for the
assay: 1 mM,  0.1 mM,  0.01 mM,  1 M,  0.1 M,  0.01 M and 1 nM.
The assay was  set up in a 48-well plate with each well containing
1 ml  of drug or M9  buffer as a control and then 20 l of worms
in M9  Buffer (approximately 50 worms) was added to each well.
The plate was  left to incubate at 19 ◦C for 40 min  before the worms
were scored using an inverted microscope. Worms were scored as
‘moving’ or ‘paralyzed’. Most worms  fell clearly into one of these
two groups, however some were observed as ‘twitching’, showing
occasional movement along part of the body length. These were
scored as ‘moving’. Each assay was completed at least three times
for each worm line. In order to test which lines showed significantly
(p < 0.05) different levamisole responses to the parent strain of C.
elegans a one-way ANOVA and the post hoc Dunnett’s test was  used,
this analysis was  carried out using Graph Pad Prism 5 software.
46 M.A. Sloan et al. / Molecular & Biochemical Parasitology 204 (2015) 44–50

































ig. 1. Confocal images of two  individual C. elegans expressing GFP under the contr
mages, (B) and (E) are the transmitted light images and (C) and (F) are the merge
ells.
. Results
.1. The unc-38 promoter drives GFP expression in muscle cells
We  sub-cloned the unc-29 and unc-38 upstream regions into
PD95.75, upstream of the GFP coding sequence, and used biolistics
o transform these constructs into N2 C. elegans. Following transfor-
ation, fluorescence was observed in body-wall, head and vulval
uscle cells. Fig. 1 shows two images of individual worms con-
aining the punc-38:GFP constructs. These animals were not from
loned lines expressing the GFP, but it is clear from both sets of
mages that there is mosaicism in the expression patterns observed.
.2. Expression of Hco-UNC-38 rescues the behavioral and
harmacological defects in an unc-38 knock-out mutant of C.
legans
We  transformed the unc-38 knock-out strain of C. elegans,
C2937, with plasmids containing either the Hco-unc-38 or Asu-
nc-38 cDNA behind the C. elegans unc-38 upstream sequence,
ogether with myo-2:GFP. After the transformation, worms show-
ng GFP expression in the pharyngeal muscle cells were picked.
ultiple such worms were observed following transformation with
co-unc-38, and these worms also showed considerably greater
otility than the parent VC2937 animals (Supplementary movies
 & 2). This made them very easy to identify, as VC2937 worms are
ery sluggish and slow-growing. We  selected independent lines of
C2937 transformed with Hco-unc-38 cDNA and demonstrated, by
CR, that they contained the transgene. Positive PCR amplifications
or two lines, HNC38/C and HMC38/J, are shown in Fig. 2A and iden-
ical results were obtained from the other lines (data not shown).
e then tested the effect of a single concentration of levamisole,
00 M,  to paralyze these strains. As shown in Fig. 2B, nearly all
95.9 ± 5.7%; n = 17) of the wild-type C. elegans were paralyzed after
5 min  incubation in the drug, as opposed to 32.7 ± 4.3% (n = 3)
f the VC2937 animals. A much higher proportion (77.3–94.0%,he unc-38 promoter sequence used in these studies. Panels (A) and (D) are the GFP
ges. bwm = body wall muscle cells, hm = head muscle cells and vm = vulval muscle
depending on the strain; n = 3 for each strain) of the individual
worms in all of the transgenic strains tested were also paralyzed
by this incubation, suggesting that the parasite UNC-38 subunit
had restored drug sensitivity to the mutant strain. In order to con-
firm this, we examined the dose-response relationship between
levamisole and paralysis for the parent and transformed strains
and found that in all cases the response of the transformed lines
was almost identical to that of N2, and completely different from
that of VC2937 (p < 0.0001). Dose-response curves for three lines
are shown in Fig. 2C; the results for all the other PCR-positive lines
tested were almost identical, but have been omitted in order to
reduce the complexity of the graph.
In contrast to the results obtained with Hco-unc-38, we were
unable to obtain any worms  that exhibited more robust locomotion
following transformation with Asu-unc-38, as we were unable to
identify any progeny expressing or containing this cDNA.
3.3. Expression of Hco-unc-29 and Asu-unc-29 only partially
rescues levamisole resistance
We  carried out similar experiments to introduce the Hco-unc-
29.1 and Asu-unc-29 cDNAs into the unc-29 knock-out mutant
VC1944, along with myo-2:GFP as a marker for transformation.
Identification of transformants was not as straightforward as with
VC2937, since the motility of VC1944 animals is similar to that
of wild-type. We were able to isolate multiple lines expressing
GFP in the pharynx following these transformations and several
of these contained the parasite cDNA, as assessed by PCR on sin-
gle adult worms  (Fig. 3). When the cDNA-containing lines were
tested for their ability to continue to move after a 45-minute expo-
sure to 10 M levamisole only 3 out of 11 lines containing the
Hco-unc-29.1 cDNA that we  tested, HMC29/3 (41.7 ± 12.8%, n = 3),
HMC29/8 (49.0 ± 7.7%, n = 3) and HMC29/12 (28.7 ± 15.3%, n = 3),
showed statistically significantly increased susceptibility to lev-
amisole compared to VC1944, of which 14.6 ± 8.0% (n = 17) were
paralyzed (p = 0.0027) (Fig. 4A). This was partially confirmed in
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Fig. 2. (A) Agarose gel (1%) demonstrating the amplification of Hco-unc-38 cDNA from individual worms of transgenic lines. M = 1 kbp markers (Promega), ‘+’ = positive





























s  indicative of the presence of the H. contortus unc-38 sequences in the strain. (B) Pa
o  10 M levamisole. In all cases p < 0.0001 compared to VC2937. (C) Dose-response
 ≥ 3 and the errors bars indicate ±SEM.
ose-response experiments (Fig. 4B), though none of the lines
howed complete rescue to wild-type levamisole sensitivity.
When we assessed the sensitivity of worms from the four lines
ontaining the Asu-unc-29 cDNA to 10 M levamisole, none of
hem showed any statistically significant difference in response to
C1944, (Fig. 5A). However, a higher proportion (79.1 ± 1.57%) of
he worms from one of the lines, ASC29/3, was paralyzed at 100 M
rug, compared to those of VC1944 (46.65 ± 7.18%; p = 0.0116),
gain suggestion a partial rescue of the drug resistance phenotype
y the parasite sub-unit (Fig. 5B).
Since the effects of expressing the parasite UNC-29 subunits on
he drug sensitivity of VC1944 was limited, we examined the move-
ent of two lines, HMC29/8 and ASC29/3 in order to see if this
rovided further evidence for the expression of the two  proteins
n the transgenic strains. Analysis of the motility of some of unc-29
ransformants using the ‘Worminator’ [28], essentially a ‘thrashing’
ssay, showed that adult HMC29/8 were significantly more mobile
han the host strain, VC1944 (p = 0.028), whereas those of ASU29/3
ere not (p = 0.22) (Fig. 6). These data provided additional evidence
hat the HCO-UNC-29.1 subunit was expressed in HMC29/8 and had
n effect on the neuromuscular function of this strain.
. Discussion
There have been many reports of the successful expression of
enes or cDNAs derived from parasitic nematodes in the model
rganism, C. elegans.  However, the majority of these have involved
ene products that are active as monomers, or can form functional
omo-multimers. This includes our previous study on glutamate-
ated chloride channels from H. contortus, where the ability ofs of transgenic VC2937 C. elegans lines expressing Hco-UNC-38 by 45 min exposure
 for levamisole-induced paralysis of transgenic VC2937 lines. For panels (B) and (C)
Hco-GLC-3, Hco-GLC-5 and Hco-GLC-6 to rescue ivermectin resis-
tance [2]. parallels their ability to form functional homomeric
channels in vitro [20,29]. In contrast, the levamisole-sensitive nico-
tinic acetylcholine receptors studied to date are all composed of
multiple subunits, which must assemble with each other and often
interact with several chaperones in order to form a functional chan-
nel [11,13,14,16]. This poses a far greater challenge to the successful
expression of individual subunits from parasitic species, which may
be an essential step on the road to a reconstitution of a full parasite
nAChR in C. elegans. Given the importance of nAChR as anthelmintic
targets, both of ‘old’ and ‘new’ drugs [10], we examined the abil-
ity of two  subunits, UNC-29—a non- subunit—and UNC-38—an 
subunit, derived from two parasitic species, A. suum (clade 3) and
H. contortus (clade 5) to express and co-assemble with the other
components of the C. elegans levamisole-sensitive receptor.
We confirmed that the promoter sequences we used were capa-
ble of driving expression of GFP in body-wall, head and vulval
muscle cells (Fig. 1), but the individual worms we  examined (which
were not derived from a clonal line) showed mosaic expression pat-
terns. If this result was  repeated in the transformed lines, some of
the muscle cells would express the parasite receptor and that this
might influence their ability to rescue the drug resistance pheno-
type. This would be a greater problem with the unc-29 experiments
than with those using unc-38, as the severe paralysis of the VC2937
strain made it easy to identify individuals in which the phenotype
had been rescued. The UNC-38 of H. contortus is able to completely
rescue the locomotion and drug-resistance phenotypes we tested,
indicating that it is capable of assembling with the other C. elegans
subunits to form a fully functional receptor, which is also capable
of interacting with the chaperones and other factors required for
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Fig. 3. Identification of VC1944-derived transgenic lines containing Hco-unc-29.1
or  Asu-unc-29 cDNA by single worm PCR. (A) Identification of lines containing Hco-
unc-29.1. Lane 1 is a negative control (N2), lanes 3–13 are amplifications on single
worms  showing pharyngeal expression of GFP. M = 1 kbp markers. The amplifica-
tion product of ∼1500 bp indicates the presence of the H. contortus unc-29 DNA.























Fig. 4. (A) Effects of incubation in 10 M levamisole for 45 min  on VC1944-derived
lines containing the Hco-unc-29.1 cDNA. *p < 0.05 compared to VC1944. (B) Dose-
response curves for some of the lines. N ≥ 3 in all cases.
Fig. 5. (A) Effects of incubation in 10 M levamisole for 45 min  on VC1944-derivednc-29 cDNA), lane 2 is a negative control (N2), lanes 3–7 are amplifications from
ndividual worms exhibiting pharyngeal GFP expression. The amplification product
f  ∼1500 bp in lanes 3, 5 and 7 indicate presence of the A. suum unc-29 DNA.
ost-synaptic expression [11,13,30–32]. In contrast, we could not
roduce any rescue of locomotion following introduction of the
su-unc-38 cDNA into the same VC2937 strain. If any ASU-UNC-
8 protein was produced following this introduction, which we
elieve is likely given that exactly the same methods were used
s for the successful experiments with the H. contortus cDNA, it
as presumably incapable of associating with the C. elegans recep-
or proteins and/or chaperones. The two UNC-29 proteins showed
t best a partial rescue of drug sensitivity. This is despite the evi-
ence that both the subunits contribute to functional receptors in
he Xenopus oocyte [16], which confirms that the cDNAs do encode
unctional subunits. The evidence suggests that both the H. contor-
us and A. suum subunits might co-assemble with the endogenous
. elegans subunits and chaperones to form functional receptors,
ased on a slightly increased thrashing activity of HMC29/8 com-
ared to N2 or the knock-out mutant strain, VC1944, and a slightly
ncreased levamisole sensitivity of three out of eleven tested lines
hat contained the Hco-unc-29.1 cDNA and one out of four that
ontained Asu-unc-29, but that these receptors either did not con-
lines containing the Asu-unc-29 cDNA. None of the lines showed any statistically
significant differences from VC1944. (B) Dose-response curves for some of these
lines. *Indicates the single point at which ASC29/3 gave a significantly different
response from VC1944 (p = 0.0116). N ≥ 3 in all cases.
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endent experiments for each strain shown). All recordings were for 30 s at room
emperature. Mmu  = mean motility units calculated by the WormAssay program as
reviously described [28].
ain a high-affinity levamisole binding site, or were not present
t neuromuscular junctions at very high levels. It is also possible
hat the expression levels of the parasite UNC-29 subunits was  not
ufficient to allow them to assemble with the C. elegans proteins.
t is worth noting that H. contortus possesses four copies of unc-
9 [13,33,34] and it possible that copies other than the one used
ere (Hco-unc-29.1) would co-assemble better with the C. elegans
omponents. The unc-29 mutant strain, VC1944, exhibits almost
ormal locomotion, in contrast to the unc-38 deletion, which is
ossibly a little surprising since the ok2450 allele is a large dele-
ion that would be expected to cause a functionally null mutation.
he absence of either UNC-29 or UNC-38 prevents the formation
f a functional receptor in vitro [11], but it is possible that in vivo
nother non- subunit, such as ACR-2 or ACR-3, may  be able to sub-
titute for UNC-29. ACR-2 and ACR-3 have both been reported to
orm functional receptors when co-expressed with UNC-38 [35,36].
f this does occur, then it would obviously complicate the analysis
f experiments such as those reported here.
Overall, our data show that receptor subunit cDNAs from the
ore closely related parasite, H. contortus, may  be better able to
escue C. elegans mutations than those of the more distantly-related
. suum. Though possibly not surprising, this does indicate that it
ight be possible to fully express a nicotinic receptor from a clade V
ematode, which includes many important veterinary and human
arasites, in C. elegans. Recent developments in CRSIPR/Cas-9 tech-
ology, including its application to C. elegans [37–39], are likely to
ake such studies much easier in the future.
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